CHROMOBLASTOMYCOSIS

This adverse event was reported 85 times

CHROMOBLASTOMYCOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BARICITINIB 3 0.0010
1 ITRACONAZOLE 11 0.0009
2 TERBINAFINE HYDROCHLORIDE TABLET 6 0.0008
3 TERBINAFINE HYDROCHLORIDE 6 0.0007
4 SELUMETINIB 1 0.0006
5 MYCOPHENILIC ACID 8 0.0004
6 MICAFUNGIN SODIUM 2 0.0003
7 TACROLIMUS OINTMENT 0.1% 38 0.0003
8 TACROLIMUS EXTENDED-RELEASE CAPSULES 38 0.0003
9 CANAKINUMAB 3 0.0003
See all drugs enriched for association with CHROMOBLASTOMYCOSIS